一个贝叶斯模型利用多个外部数据源来提高转移性非小细胞肺癌中终身存活推断的可靠性
Daniel J Sharpe1, Georgia Yates1, Mohammad Ashraf Chaudhary2
1Parexel, London, UK.
概括
贝叶斯多参数证据综合 (B-MPES) 通过结合历史试验数据,改善了转移性非小细胞肺癌的长期生存预测. 当研究数据未成熟时,这种方法提高了可靠性,提供了更合理的生命周期推断.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 卫生经济学 卫生经济学
背景情况:
- 可靠的长期生存外推对于新型癌症疗法至关重要.
- 早期试验数据往往缺乏足够的后续研究,无法为确切的生存预测做出准确的预测.
- 登记册和历史试验数据可以补充早期研究信息.
研究的目的:
- 扩展贝叶斯的多参数证据综合 (B-MPES) 以纳入历史试验数据.
- 评估外部数据源对早期数据削减的生存预测的影响.
- 将B-MPES预测与转移性非小细胞肺癌 (mNSCLC) 的标准参数模型 (SPM) 进行比较.
主要方法:
- 将B-MPES模型与CheckMate 9LA研究中的生存数据相匹配 (尼沃卢马布加上伊皮利穆马布加上化疗与化疗).
- 试验数据与注册表数据 (SEER) 和历史试验数据 (调整为混) 补充.
- 将B-MPES预测与使用早期和4年数据削减的SPM进行了比较.
主要成果:
- 与SPM相比,B-MPES模型更好地捕捉了在以后的数据削减中观察到的生存平原.
- SPM产生了过于保守的短期生存推断.
- 使用历史NIVO+IPI数据的B-MPES模型略高估计了由于未解决的危险混而导致的生存率.
结论:
- 通过B-MPES将历史试验数据纳入新疗法的终身存活推断的可信性,提高了未成熟数据的新疗法的可信性.
- 通过利用多个外部数据源,B-MPES提供了一种透明的生存外推方法.
- 仔细规范模型灵活性和先前数据可靠性至关重要,以避免B-MPES过度拟合.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
633
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.6K
相关概念视频
Kaplan-Meier Approach
547
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Parametric Survival Analysis: Weibull and Exponential Methods
1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K
